Manufacturing roundup: AstraZeneca widens partnership in Abu Dhabi; Moderna finalizes its partnership with the UK
UK-based AstraZeneca and Abu Dhabi-based G42 Healthcare have inked a strategic manufacturing deal to make drugs in the capital of the United Arab Emirates.
The manufacturing deal will focus on R&D and “localizing” industries to produce pharma products, as AstraZeneca also has “ongoing efforts” with the Department of Health of Abu Dhabi.
Abu Dhabi has unveiled plans to double the size of its manufacturing sector by 2031, and this deal plays into that forecast, as both G42 and AstraZeneca collaborate to boost exports of drug products and collaborate on research projects.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.